Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD4 Recovery in HIV-1: PI vs NNRTI Regimens
NCT00966160Phase 3Completed
- Sponsor
- University of Cologne
- Start
- Jan 1999
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lopinavir + ritonavir, efavirenz in human immunodeficiency virus type 1 infection (HIV-1), sponsored by University of Cologne. Started Jan 1999; status: completed.
02
Drugs
lopinavir + ritonavirefavirenz
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00966160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00966160.